Our study demonstrated the important of p90RSK activation in immunosenescence (370) and atherosclerosis inhibition (394), indicating the potential significance of p90RSK-mediated ERK5 S496 phosphorylation in SASP and SAS regulation, and its implications for CVD and cancer treatment resistance. This evidence concerns the gene RPS6KA1 and atherosclerosis.